Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
about
Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian HamstersAnimal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and HantavirusesThe Syrian hamster model of hantavirus pulmonary syndromeAntiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposureDNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelPathology of Puumala hantavirus infection in macaquesImmunological mechanisms mediating hantavirus persistence in rodent reservoirs.Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus).Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.Recent approaches in hantavirus vaccine development.Pneumonitis in Syrian golden hamsters (Mesocricetus auratus) infected with Rio Mamoré virus (family Bunyaviridae, genus Hantavirus)Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.Human pathogenic hantaviruses and prevention of infectionProtective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responsesConstruction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.Hantavirus cardiopulmonary syndrome successfully treated with high-volume hemofiltration.Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virusA lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.Gastrointestinal Tract As Entry Route for Hantavirus Infection.
P2860
Q26314485-3A7CE02A-C49B-4C59-8472-AF9801290301Q26798695-D70A2711-63FD-42A4-9076-377394D79635Q27027405-2EABB3E5-788F-4275-8359-00FD7EC0D096Q27304441-55E64FAF-0EE0-4544-8EA2-0D10193F47F9Q28730275-BD011384-4766-4C75-A100-A34E29D5980FQ28741304-FEE497FE-83AA-49B1-889B-68E9AFCB08A6Q33361954-BAC3838A-4B6F-4267-B24B-6A17EE7CF1ABQ33388243-9D15F0F6-1BAC-40E9-81D8-F3508380BE6BQ33439713-8BD840EA-A2D9-42C1-877B-28E2351ECCEDQ33451204-4F7D0058-8744-4AF2-A449-674DE8223F2BQ33558721-5C469475-8C94-4588-AEAD-5CA9F1A8198EQ33567784-2DAA983E-C21B-4AF9-A5A9-CBE436257AFBQ34165062-33E70C92-0178-49D3-8146-A608F3505B06Q34602147-C075B618-272D-407D-8F83-EFD050A1C74EQ34610482-6D4C2D0B-9364-443E-848A-BA375BE58EDCQ35339702-DA03C50B-6380-48EB-9256-17447FD1FA3EQ35383088-9B2D44E3-8241-4464-88E5-FD983660CF34Q35531542-88C04E52-0282-4010-B991-1917E2AC1EB1Q35558535-A58E8502-B003-463C-8CE8-8022ACE64818Q36044109-084FBB27-4BBF-40E7-8381-A8ACD8700658Q36606789-4AF6DF6A-FC8E-4371-8C41-A722B38B0E08Q36694022-0CE57FC3-8B6F-4AE5-AF5C-49017A9A3716Q37090235-214E0CBC-2F08-4EEE-91F9-9957F142E687Q37247930-61E66B41-D335-4832-A146-7773BE0647DEQ37263923-7A66B209-6F8D-4F7D-A69E-5EA11C9B544EQ37365029-8E96C29B-9599-4E8C-A52C-DF50A4EF66B5Q37376384-DA8F3E9E-2A7E-4EC5-8781-7A8173D1C66BQ37547578-8D3BC59C-0C37-4BC9-ADD4-913184360030Q41646078-C4989908-20A2-4AD3-9FF4-7BDC20C4DADDQ41699596-AE97F6A4-FD43-4939-8803-D5B81ABE3143
P2860
Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@ast
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@en
type
label
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@ast
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@en
prefLabel
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@ast
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@en
P2860
P356
P1433
P1476
Immune serum produced by DNA v ...... ry challenge with Andes virus.
@en
P2093
Anthony M Ferro
Victoria Wahl-Jensen
P2860
P304
P356
10.1128/JVI.01822-07
P407
P577
2007-11-21T00:00:00Z